Leidos Wins $318M Contract for MHS GENESIS Transition Support
LDOS sits 21% above its 52-week low of $98.86.
Summary
Leidos secured a $318 million contract to support the transition of MHS GENESIS, the military's electronic health record system. The award adds to a string of recent defense and intelligence wins, including a $717 million Air Force task order in July and a $64.8 million Navy contract in August. With Q2 revenue of $4.56 billion and raised full-year EPS guidance, this contract reinforces the company's growth momentum in government health IT. The deal is modest relative to Leidos' size but signals continued expansion in a key federal market.
At the time of this announcement, LDOS was trading at $119.70 on NYSE in the Technology sector, with a market capitalization of approximately $15B. The 52-week trading range was $98.86 to $205.77. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Seeking Alpha.